Skip to main content

NEUROMODULACION DE LAS VIAS INHIBITORIAS MEDIANTE FOTOFARMACOLOGIA ACTIVADA POR LUZ ROJA E INFRARROJA.

PID2019-111493RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Light-dependent inhibition of clathrin-mediated endocytosis in yeast unveils conserved functions of the AP2 complex

  • Prischich, Davia
  • Camarero, Núria
  • Encinar del Dedo, Javier
  • Cambra Pellejà, Maria
  • Prat, Judit
  • Nevola, Laura
  • Martín Quirós, Andrés
  • Rebollo, Elena
  • Pastor, Laura
  • Giralt, Ernest
  • Geli, María Isabel
  • Gorostiza, Pau
[EN] Clathrin-mediated endocytosis (CME) is an essential cellular process, conserved among eukaryotes. Yeast constitutes a powerful genetic model to dissect the complex endocytic machinery, yet there is a lack of specific pharmacological agents to interfere with CME in these organisms. TL2 is a light-regulated peptide inhibitor targeting the AP2-β-adaptin/β-arrestin interaction and that can photocontrol CME with high spatiotemporal precision in mammalian cells. Here, we study endocytic protein dynamics by live-cell imaging of the fluorescently tagged coat-associated protein Sla1-GFP, demonstrating that TL2 retains its inhibitory activity in S. cerevisiae spheroplasts. This is despite the β-adaptin/β-arrestin interaction not being conserved in yeast. Our data indicate that the AP2 α-adaptin is the functional target of activated TL2. We identified as interacting partners for the α-appendage, the Eps15 and epsin homologues Ede1 and Ent1. This demonstrates that endocytic cargo loading and sensing can be executed by conserved molecular interfaces, regardless of the proteins involved, SI, This research received funding from the European Union Research and Innovation Programme Horizon 2020 - Human Brain Project SG3 (945539) to P.G., DEEPER (ICT-36-2020-101016787) to P.G., Agency for Management of University and Research Grants/Generalitat de Catalunya (CERCA Program; 2017-SGR-1442 and 2017-SGR-00465 projects) to P.G., Fonds Europe´ en de De´ velopement E´ conomique et Re´gional (FEDER) funds, Ministry of Science and Innovation (Grant PID2019-111493RB-I00), Fundaluce and "la Caixa" foundations (ID 100010434, agreement LCF/PR/ HR19/52160010) to P.G. The project Clu´ ster Emergent del Cervell Huma` (CECH, 001-P-001682) to P.G. is co-financed by the European Union Regional Development Fund within the framework of the ERDF Operational Program of Catalonia 2014-2020 with a grant of 50% of total eligible cost. IBEC and IRB Barcelona are recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). BFU2017-82959-P & PID2020-120053GB-I00 from MINECO to M.I.G. D.P. was supported by fellowship BES-2015-072657. L. P. was supported by fellowship PRE2018- 083198
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Photoswitchable COX-2-Selective Inhibitors as Light-Regulated Anti-Inflammatory Agents

  • Morales Jiménez, Amanda
  • Cruz, Alejandro
  • Pérez-Sánchez, Álex|||0000-0003-3636-3885
  • D'Avino, Danilo
  • Galassi, Gaia
  • Milano, Erica Ginevra
  • Bernareggi, Irene
  • Arenós-Bach, Carla|||0009-0002-0297-539X
  • Grazioso, Giovanni
  • Alibés, Ramon|||0000-0002-7997-2691
  • Hernando, Jordi|||0000-0002-1126-4138
  • Gorostiza, Pau|||0000-0002-7268-5577
  • Rossi, Antonietta
  • Pistocchi, Anna
  • Matera, Carlo|||0000-0001-6939-3859
  • Busqué, Félix|||0000-0001-7566-4264
  • González Lafont, Àngels|||0000-0003-0729-2483
  • Lluch, José M.|||0000-0002-7536-1869
Despite their extensive use, the therapeutic potential of nonsteroidal anti-inflammatory drugs (NSAIDs) remains significantly constrained by adverse side effects. This limitation primarily arises from insufficient selectivity, as current NSAIDs inhibit not only the inducible cyclooxygenase-2 (COX-2) isoform at sites of inflammation but also constitutive COX-2 in healthy tissues and, frequently, cyclooxygenase-1. To address this challenge, we developed photoswitchable NSAIDs that combine COX-2 selectivity with light-controlled activity to enable spatiotemporal confinement of the therapeutic effect at inflamed tissues. Following computational design and screening of a library of azoaromatic derivatives of celecoxib─the most widely used COX-2 selective NSAID─three photoswitchable analogues were synthesized, which exhibited reversible and efficient trans-cis photoconversion. Light-controlled and selective COX-2 inhibition was demonstrated for these compounds in vitro, reaching up to 5-fold potency enhancement in macrophage assays upon photoisomerization from the initial, dark-adapted trans isomer to the cis state. The best candidate displayed in vivo efficacy in a zebrafish model of acute inflammation, where administration of the photoinduced cis form reduced leukocyte recruitment at the wound site. These findings position photoswitchable NSAIDs as a promising alternative to conventional drugs for treating inflammation and related conditions, including cancer.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Brain state identification and neuromodulation to promote recovery of consciousness

  • Van Der Lande, Glenn J. M.
  • Casas-Torremocha, Diana
  • Manasanch, Arnau
  • Dalla Porta, Leonardo
  • Gosseries, Olivia
  • Alnagger, Naji
  • Barra, Alice
  • Mejias, Jorge F.
  • Panda, Rajanikant
  • Riefolo, Fabio
  • Thibaut, Aurore
  • Bonhomme, Vincent
  • Thirion, Bertrand
  • Clasca, Francisco
  • Gorostiza, Pau
  • Sanchez-Vives, Maria V.
  • Deco, Gustavo
  • Laureys, Steven
  • Zamora-López, Gorka
  • Annen, Jitka
Experimental and clinical studies of consciousness identify brain states (i.e. quasi-stable functional cerebral organization) in a non-systematic manner and largely independent of the research into brain state modulation. In this narrative review, we synthesize advances in the identification of brain states associated with consciousness in animal models and physiological (sleep), pharmacological (anaesthesia) and pathological (disorders of consciousness) states of altered consciousness in humans. We show that in reduced consciousness the frequencies in which the brain operates are slowed down and that the pattern of functional communication is sparser, less efficient, and less complex. The results also highlight damaged resting-state networks, in particular the default mode network, decreased connectivity in long-range connections and especially in the thalamocortical loops. Next, we show that therapeutic approaches to treat disorders of consciousness, through pharmacology (e.g. amantadine, zolpidem), and (non-) invasive brain stimulation (e.g. transcranial direct current stimulation, deep brain stimulation) have shown partial effectiveness in promoting consciousness recovery. Although some features of conscious brain states may improve in response to neuromodulation, targeting often remains non-specific and does not always lead to (behavioural) improvements. The fields of brain state identification and neuromodulation of brain states in relation to consciousness are showing fascinating developments that, when integrated, might propel the development of new and better-targeted techniques for disorders of consciousness. We here propose a therapeutic framework for the identification and modulation of brain states to facilitate the interaction between the two fields. We propose that brain states should be identified in a predictive setting, followed by theoretical and empirical testing (i.e. in animal models, under anaesthesia and in patients with a disorder of consciousness) of neuromodulation techniques to promote consciousness in line with such predictions. This framework further helps to identify where challenges and opportunities lay for the maturation of brain state research in the context of states of consciousness. It will become apparent that one angle of opportunity is provided through the addition of computational modelling. Finally, it aids in recognizing possibilities and obstacles for the clinical translation of these diagnostic techniques and neuromodulation treatment options across both the multimodal and multi-species approaches outlined throughout the review., NA is research fellow, OG and AT are Research Associates, and SL is the research director at Fonds de la Recherche Scientifique (FRS-FNRS). JA is a postdoctoral fellow at the Fonds voor Wetenschappelijk Onderzoek (FWO) (1265522N). The study was further supported by the University and University Hospital of Liège, the BIAL Foundation, the Belgian National Funds for Scientific Research (FRS-FNRS), the European Union's Horizon 2020 Framework Programme for Research and Innovation under Specific Grant Agreement No. 945539 (Human Brain Project SGA3), the FNRS PDR project (T.0134.21), the ERA-Net FLAG-ERA JTC2021 project ModelDXConsciousness (Human Brain Project Partnering Project), the fund Generet, the King Baudouin Foundation, the Télévie Foundation, the European Space Agency (ESA) and the Belgian Federal Science Policy Office (BELSPO) in the framework of the PROgramme de Développement d'Expériences scientifiques (PRODEX Programme), the Public Utility Foundation `Université Européenne du Travail', `Fondazione Europea di Ricerca Biomedica', the BIAL Foundation, the Mind Science Foundation, the European Commission, the Fondation Leon Fredericq, the Mind-Care foundation, the DOCMA project (EU-H2020-MSCA-RISE-778234), the National Natural Science Foundation of China (Joint Research Project 81471100) and the European Foundation of Biomedical Research (FERB Onlus). EU grants ICT-36-2020-101016787 (DEEPER), EIC Pathfinder GAP-101130883 (PHOTOTHERAPORT), and -EIC-2023-PATHFINDEROPEN-101130650 (META-BRAIN), Government of Catalonia AGAUR [Centres de Recerca de Catalunya (CERCA) Programme, 2021-SGR-01410; AGAUR 2021-SGR-01165 - NEUROVIRTUAL], Ministerio de Ciencia e Innovación (MICINN) grants PID2019-111493RB-I00 (DEEP RED) and PID2022- 142609OB-I00 (EPILLUM), PID2020-112947RB-I00 financed by Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI)/10.13039/501100011033 (CORTICOMOD), and Fundaluce and 'la Caixa' foundations (ID 100010434, agreement LCF/PR/HR19/52160010).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Reversible photocontrol of dopaminergic transmission in wild-type animals

  • Matera, Carlo
  • Calvé Pérez, Pablo, 1993-
  • Casadó-Anguera, Verònica
  • Sortino, Rosalba
  • Gomila, Alexandre M.J.
  • Moreno, Estefanía
  • Gener, Thomas
  • Delgado-Sallent, Cristina
  • Nebot Forcada, Pau
  • Costazza, Davide
  • Conde-Berriozabal, Sara
  • Masana, Mercè
  • Hernando, Jordi
  • Casadó, Vicent
  • Puig Velasco, María Victoria
  • Gorostiza, Pau
Understanding the dopaminergic system is a priority in neurobiology and neuropharmacology. Dopamine receptors are involved in the modulation of fundamental physiological functions, and dysregulation of dopaminergic transmission is associated with major neurological disorders. However, the available tools to dissect the endogenous dopaminergic circuits have limited specificity, reversibility, resolution, or require genetic manipulation. Here, we introduce azodopa, a novel photoswitchable ligand that enables reversible spatiotemporal control of dopaminergic transmission. We demonstrate that azodopa activates D1-like receptors in vitro in a light-dependent manner. Moreover, it enables reversibly photocontrolling zebrafish motility on a timescale of seconds and allows separating the retinal component of dopaminergic neurotransmission. Azodopa increases the overall neural activity in the cortex of anesthetized mice and displays illumination-dependent activity in individual cells. Azodopa is the first photoswitchable dopamine agonist with demonstrated efficacy in wild-type animals and opens the way to remotely controlling dopaminergic neurotransmission for fundamental and therapeutic purposes., This research was funded by EU Horizon 2020 Framework Programme for Research and Innovation: Human Brain Project WaveScalES, Specific Grant Agreement 2 No. 785907 and Specific Grant Agreement 3 No. 945539; NEUROPA project, Grant Agreement No. 863214; DEEPER project ICT-36-2020-101016787; European Union Regional Development Fund within the framework of the ERDF Operational Program of Catalonia 2014-2020: CECH project; Ministry of Science and Innovation DEEP RED grant PID2019-111493RB-I00 funded by MCIN/AEI/10.13039/501100011033; Ministerio de Economía y Competitividad and European Regional Development Funds: Grant no. SAF2017-87629-R to V.C., SAF2016-80726-R to M.V.P., SAF2017-88076-R to M.M.; AGAUR/Generalitat de Catalunya: CERCA Programme; Generalitat de Catalunya: Grant no. 2017-SGR-1442 to P.G., 2017-SGR-1497 to V.C., 2017-SGR-210 to M.V.P., and 2017-SGR-00465 to J.H.; Fundaluce and “la Caixa” foundations: ID 100010434, grant agreement LCF/PR/HR19/52160010.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

Photoswitchable Carbamazepine Analogs for Non-Invasive Neuroinhibition In Vivo

  • Camerin, L.
  • Maleeva, G.
  • Gomila, A.M.J
  • Suárez-Pereira, Irene
  • Matera, C.
  • Prischich, D.
  • Opar, E.
  • Riefolo, F.
  • Berrocoso Domínguez, Esther María
  • Gorostiza, P.
A problem of systemic pharmacotherapy is off-target activity, which causes adverse effects. Outstanding examples include neuroinhibitory medications like antiseizure drugs, which are used against epilepsy and neuropathic pain but cause systemic side effects. There is a need of drugs that inhibit nerve signals locally and on-demand without affecting other regions of the body. Photopharmacology aims to address this problem with light-activated drugs and localized illumination in the target organ. Here, we have developed photoswitchable derivatives of the widely prescribed antiseizure drug carbamazepine. For that purpose, we expanded our method of ortho azologization of tricyclic drugs to meta/para and to N-bridged diazocine. Our results validate the concept of ortho cryptoazologs (uniquely exemplified by Carbazopine-1) and bring to light Carbadiazocine (8), which can be photoswitched between 400–590 nm light (using violet LEDs and halogen lamps) and shows good drug-likeness and predicted safety. Both compounds display photoswitchable activity in vitro and in translucent zebrafish larvae. Carbadiazocine (8) also offers in vivo analgesic efficacy (mechanical and thermal stimuli) in a rat model of neuropathic pain and a simple and compelling treatment demonstration with non-invasive illumination.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Ratiometric Nanothermometer Based on a Radical Excimer for In Vivo Sensing

  • Blasi, Davide
  • Gonzalez Pato, Nerea 
  • Rodríguez Rodríguez, Xavier
  • Díez Zabala, Íñigo
  • Srinivasan, Sumithra Y.
  • Camarero, Núria
  • Esquivias, Oriol
  • Roldán, Mònica
  • Guasch, Judit
  • Laromaine, Anna
  • Gorostiza, Pau
  • Veciana, Jaume
  • Ratera, Immaculada
Ratiometric fluorescent nanothermometers with near-infrared emission play an important role in in vivo sensing since they can be used as intracellular thermal sensing probes with high spatial resolution and high sensitivity, to investigate cellular functions of interest in diagnosis and therapy, where current approaches are not effective. Herein, the temperature-dependent fluorescence of organic nanoparticles is designed, synthesized, and studied based on the dual emission, generated by monomer and excimer species, of the tris(2,4,6-trichlorophenyl)methyl radical (TTM) doping organic nanoparticles (TTMd-ONPs), made of optically neutral tris(2,4,6-trichlorophenyl)methane (TTM-αH), acting as a matrix. The excimer emission intensity of TTMd-ONPs decreases with increasing temperatures whereas the monomer emission is almost independent and can be used as an internal reference. TTMd-ONPs show a great temperature sensitivity (3.4% K-1 at 328 K) and a wide temperature response at ambient conditions with excellent reversibility and high colloidal stability. In addition, TTMd-ONPs are not cytotoxic and their ratiometric outputs are unaffected by changes in the environment. Individual TTMd-ONPs are able to sense temperature changes at the nano-microscale. In vivo thermometry experiments in Caenorhabditis elegans (C. elegans) worms show that TTMd-ONPs can locally monitor internal body temperature changes with spatio-temporal resolution and high sensitivity, offering multiple applications in the biological nanothermometry field., D.B. and N.G.-P. contributed equally to this work. The authors are grateful for the financial support received from the Spanish Government (PID2020-115296RA-I00, PID2019-105622RB-I00, PDI2021-122645OB-I00, RTI2018-096273-B-I00 and PID2019-111493RB-I00) funded by MICIN and the “Ramón y Cajal” program (RYC-2017-22614), the Generalitat de Catalunya (SGR-918, 2017SGR765, SGR Cat 2021-00438, 2017-SGR-1442, and 2021-SGR-1410, 2021-SGR-00446), and the Networking Research Center on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN). DB gratefully acknoledges the REFIN (Return for Future Innovation) action for funding, an ininitiative co - funded by European Union through the POR Puglia 2014 - 2020 (ID grant: 2455F798). This research was also supported by the European Union's Horizon 2020 research and innovation program H2020-MSCA-COFUND-2016 (DOC-FAM, grant agreement Nr. 754397), Human Brain Project WaveScaES (SGA2-785907 and SGA3-945539), DEEPER (ICT36-2020-101016787), and the Marie Skłodowka-Curie grant agreement Nr. 101007804 (Micro4Nano). Support from Fundaluce and CaixaHealth (ID 100010434) are also acknowledged. The work was supported as well by the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck for Medical Research (Heidelberg, Germany). ICMAB-CSIC acknowledges support from the Severo Ochoa Programme for Centres of Excellence in R&D (FUNFUTURE, CEX2019-000917-S). IBEC acknowledges support from the CERCA programme of AGAUR/Generalitat de Catalunya and the Severo Ochoa Programme. This work had been developed inside the “Biochemistry, Molecular Biology and Biomedicine” and “Materials Science” Ph.D. programs of UAB. Nerea Gonzalez-Pato acknowledges the financial support from the FPU fellowship (FPU17/02551) from the Spanish Ministry., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Light-dependent inhibition of clathrin-mediated endocytosis in yeast unveils conserved functions of the AP2 complex

  • Prischich, Davia
  • Camarero, Núria
  • Encinar del Dedo, Javier
  • Cambra-Pellejà, Maria
  • Prat, Judit
  • Nevola, Laura
  • Martín-Quirós, Andrés
  • Rebollo, Elena
  • Pastor, Laura
  • Giralt, Ernest
  • Geli, María Isabel
  • Gorostiza, Pau
Clathrin-mediated endocytosis (CME) is an essential cellular process, conserved among eukaryotes. Yeast constitutes a powerful genetic model to dissect the complex endocytic machinery, yet there is a lack of specific pharmacological agents to interfere with CME in these organisms. TL2 is a light-regulated peptide inhibitor targeting the AP2-β-adaptin/β-arrestin interaction and that can photocontrol CME with high spatiotemporal precision in mammalian cells. Here, we study endocytic protein dynamics by live-cell imaging of the fluorescently tagged coat-associated protein Sla1-GFP, demonstrating that TL2 retains its inhibitory activity in S. cerevisiae spheroplasts. This is despite the β-adaptin/β-arrestin interaction not being conserved in yeast. Our data indicate that the AP2 α-adaptin is the functional target of activated TL2. We identified as interacting partners for the α-appendage, the Eps15 and epsin homologues Ede1 and Ent1. This demonstrates that endocytic cargo loading and sensing can be executed by conserved molecular interfaces, regardless of the proteins involved., This research received funding from the European Union Research and Innovation Programme Horizon 2020 - Human Brain Project SG3 (945539) to P.G., DEEPER (ICT-36-2020-101016787) to P.G., Agency for Management of University and Research Grants/Generalitat de Catalunya (CERCA Program; 2017-SGR-1442 and 2017-SGR-00465 projects) to P.G., Fonds Européen de Dévelopement Économique et Régional (FEDER) funds, Ministry of Science and Innovation (Grant PID2019-111493RB-I00), Fundaluce and "la Caixa" foundations (ID 100010434, agreement LCF/PR/HR19/52160010) to P.G. The project Clúster Emergent del Cervell Humà (CECH, 001-P-001682) to P.G. is co-financed by the European Union Regional Development Fund within the framework of the ERDF Operational Program of Catalonia 2014-2020 with a grant of 50% of total eligible cost. IBEC and IRB Barcelona are recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). BFU2017-82959-P & PID2020-120053GB-I00 from MINECO to M.I.G. D.P. was supported by fellowship BES-2015-072657. L. P. was supported by fellowship PRE2018-083198., Peer reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Fast photochronoamperometry of photosynthetic complexes for biosensors and electron transport studies

  • López-Ortiz, Manuel
  • Zamora, Ricardo A.
  • Remesh, Vikas
  • Hu, Chen
  • Croce, Roberta
  • Hulst, Niek van
  • Gorostiza, Pau
Photosynthetic reactions in plants, algae, and cyanobacteria are driven by photosystem I and photosystem II complexes, which specifically reduce or oxidize partner redox biomolecules. Photosynthetic complexes can also bind synthetic organic molecules, which inhibit their photoactivity and can be used both to study the electron transport chain and as herbicides and algicides. Thus, their development, characterization, and sensing bears fundamental and applied interest. Substantial efforts have been devoted to developing photosensors based on photosystem II to detect compounds that bind to the plastoquinone sites of this complex. In comparison, photosystem I based sensors have received less attention and could be used to identify novel substances displaying phytotoxic effects, including those obtained from natural product extracts. We have developed a robust procedure to functionalize gold electrodes with photo- and redox-active photosystem I complexes based on transparent gold and a thiolate self-assembled monolayer, and we have obtained reproducible electrochemical photoresponses. Chronoamperometric recordings have allowed us to measure photocurrents in the presence of the viologen derivative paraquat at concentrations below 100 nM under lock-in operation and a sensor dynamic range spanning six orders of magnitude up to 100 mM. We have modeled their time course to identify the main electrochemical processes and limiting steps in the electron transport chain. Our results allow us to isolate the contributions from photosystem I and the redox mediator, and evaluate photocurrent features (spectral and power dependence, fast transient kinetics) that could be used as a sensing signal to detect other inhibitors and modulators of photosystem I activity., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Photoswitchable COX-2-selective inhibitors as light-regulated anti-inflammatory agents

  • Morales Jimenez, Amanda
  • Cruz Sáez, Alejandro|||0000-0003-0928-0718
  • Pérez Sánchez, Álex
  • D'Avino, Danilo
  • Galassi, Gaia
  • Ginevra Milano, Erica
  • Bernareggi, Irene
  • Arenós Bach, Carla
  • Grazioso, Giovanni|||0000-0002-3261-9356
  • Alibes Arques, Ramon
  • Hernando Campos, Jordi
  • Gorostiza Langa, Pau
  • Rossi, Antonietta
  • Pistocchi, Anna
  • Matera, Carlo
  • Busqué Sanchez, Felix
  • González Lafont, Àngels
  • Lluch López, Josep Maria
Despite their extensive use, the therapeutic potential of nonsteroidal anti-inflammatory drugs (NSAIDs) remains significantly constrained by adverse side effects. This limitation primarily arises from insufficient selectivity, as current NSAIDs inhibit not only the inducible cyclooxygenase-2 (COX-2) isoform at sites of inflammation but also constitutive COX-2 in healthy tissues and, frequently, cyclooxygenase-1. To address this challenge, we developed photoswitchable NSAIDs that combine COX-2 selectivity with light-controlled activity to enable spatiotemporal confinement of the therapeutic effect at inflamed tissues. Following computational design and screening of a library of azoaromatic derivatives of celecoxib-the most widely used COX-2 selective NSAID-three photoswitchable analogues were synthesized, which exhibited reversible and efficient trans-cis photoconversion. Light-controlled and selective COX-2 inhibition was demonstrated for these compounds in vitro, reaching up to 5-fold potency enhancement in macrophage assays upon photoisomerization from the initial, dark-adapted trans isomer to the cis state. The best candidate displayed in vivo efficacy in a zebrafish model of acute inflammation, where administration of the photoinduced cis form reduced leukocyte recruitment at the wound site. These findings position photoswitchable NSAIDs as a promising alternative to conventional drugs for treating inflammation and related conditions, including cancer., This work was supported by the “Ministerio de Ciencia, Innovación y Universidades” of Spain through projects PID2019-111493RB-I00, PID2022-142609OB-I00, PID2023-147140NB-I00, and PID2022-139826OB-I00. We also acknowledge CSUC (“Consorci de Serveis Universitaris de Catalunya”) for the allocation of computing resources, as well as from Generalitat de Catalunya through projects 2021 SGR 00064 and 2021 SGR 01410 and CERCA program. This study was supported by funds from the University of Milan, Piano di Sostegno alla Ricerca 2025, Linea 2. This research was supported for the in vitro studies by the Italian Ministry of University and Research (PRIN 2022 PNRR; MIUR CODE: P2022CNPH8, CUP: C53D23007850001). This research also received funding from the European Union Research and Innovation Program Horizon 2020 – Human Brain Project SG3 (945539), DEEPER (ICT-36-2020-101016787), and the European Innovation Council Pathfinder Open (PHOTOTHERAPORT, 101130883). J.H. is a Serra Húnter fellow., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Fast photochronoamperometry of photosynthetic complexes for biosensors and electron transport studies

  • López-Ortiz, Manuel
  • Zamora, Ricardo A.
  • Remesh, Vikas
  • Hu, Chen
  • Croce, Roberta
  • Hulst, Niek van
  • Gorostiza, Pau
Photosynthetic reactions in plants, algae, and cyanobacteria are driven by photosystem I and photosystem II complexes, which specifically reduce or oxidize partner redox biomolecules. Photosynthetic complexes can also bind synthetic organic molecules, which inhibit their photoactivity and can be used both to study the electron transport chain and as herbicides and algicides. Thus, their development, characterization, and sensing bears fundamental and applied interest. Substantial efforts have been devoted to developing photosensors based on photosystem II to detect compounds that bind to the plastoquinone sites of this complex. In comparison, photosystem I based sensors have received less attention and could be used to identify novel substances displaying phytotoxic effects, including those obtained from natural product extracts. We have developed a robust procedure to functionalize gold electrodes with photo- and redox-active photosystem I complexes based on transparent gold and a thiolate self-assembled monolayer, and we have obtained reproducible electrochemical photoresponses. Chronoamperometric recordings have allowed us to measure photocurrents in the presence of the viologen derivative paraquat at concentrations below 100 nM under lock-in operation and a sensor dynamic range spanning six orders of magnitude up to 100 mM. We have modeled their time course to identify the main electrochemical processes and limiting steps in the electron transport chain. Our results allow us to isolate the contributions from photosystem I and the redox mediator, and evaluate photocurrent features (spectral and power dependence, fast transient kinetics) that could be used as a sensing signal to detect other inhibitors and modulators of photosystem I activity., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Photoswitchable COX-2-selective inhibitors as light-regulated anti-inflammatory agents

  • Morales Jimenez, Amanda
  • Cruz Sáez, Alejandro
  • Pérez Sánchez, Álex
  • D'Avino, Danilo
  • Galassi, Gaia
  • Ginevra Milano, Erica
  • Bernareggi, Irene
  • Arenós Bach, Carla
  • Grazioso, Giovanni
  • Alibes Arques, Ramon
  • Hernando Campos, Jordi
  • Gorostiza Langa, Pau
  • Rossi, Antonietta
  • Pistocchi, Anna
  • Matera, Carlo
  • Busqué Sanchez, Felix
  • González Lafont, Àngels
  • Lluch López, Josep Maria
Despite their extensive use, the therapeutic potential of nonsteroidal anti-inflammatory drugs (NSAIDs) remains significantly constrained by adverse side effects. This limitation primarily arises from insufficient selectivity, as current NSAIDs inhibit not only the inducible cyclooxygenase-2 (COX-2) isoform at sites of inflammation but also constitutive COX-2 in healthy tissues and, frequently, cyclooxygenase-1. To address this challenge, we developed photoswitchable NSAIDs that combine COX-2 selectivity with light-controlled activity to enable spatiotemporal confinement of the therapeutic effect at inflamed tissues. Following computational design and screening of a library of azoaromatic derivatives of celecoxib-the most widely used COX-2 selective NSAID-three photoswitchable analogues were synthesized, which exhibited reversible and efficient trans-cis photoconversion. Light-controlled and selective COX-2 inhibition was demonstrated for these compounds in vitro, reaching up to 5-fold potency enhancement in macrophage assays upon photoisomerization from the initial, dark-adapted trans isomer to the cis state. The best candidate displayed in vivo efficacy in a zebrafish model of acute inflammation, where administration of the photoinduced cis form reduced leukocyte recruitment at the wound site. These findings position photoswitchable NSAIDs as a promising alternative to conventional drugs for treating inflammation and related conditions, including cancer., This work was supported by the “Ministerio de Ciencia, Innovación y Universidades” of Spain through projects PID2019-111493RB-I00, PID2022-142609OB-I00, PID2023-147140NB-I00, and PID2022-139826OB-I00. We also acknowledge CSUC (“Consorci de Serveis Universitaris de Catalunya”) for the allocation of computing resources, as well as from Generalitat de Catalunya through projects 2021 SGR 00064 and 2021 SGR 01410 and CERCA program. This study was supported by funds from the University of Milan, Piano di Sostegno alla Ricerca 2025, Linea 2. This research was supported for the in vitro studies by the Italian Ministry of University and Research (PRIN 2022 PNRR; MIUR CODE: P2022CNPH8, CUP: C53D23007850001). This research also received funding from the European Union Research and Innovation Program Horizon 2020 – Human Brain Project SG3 (945539), DEEPER (ICT-36-2020-101016787), and the European Innovation Council Pathfinder Open (PHOTOTHERAPORT, 101130883). J.H. is a Serra Húnter fellow., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Brain state identification and neuromodulation to promote recovery of consciousness

  • Van Der Lande, Glenn J. M.
  • Casas-Torremocha, Diana
  • Manasanch, Arnau
  • Dalla Porta, Leonardo
  • Gosseries, Olivia
  • Alnagger, Naji
  • Barra, Alice
  • Mejias, Jorge F.
  • Panda, Rajanikant
  • Riefolo, Fabio
  • Thibaut, Aurore
  • Bonhomme, Vincent
  • Thirion, Bertrand
  • Clasca, Francisco
  • Gorostiza, Pau
  • Sanchez-Vives, Maria V.
  • Deco, Gustavo
  • Laureys, Steven
  • Zamora-López, Gorka
  • Annen, Jitka
Experimental and clinical studies of consciousness identify brain states (i.e. quasi-stable functional cerebral organization) in a non-systematic manner and largely independent of the research into brain state modulation. In this narrative review, we synthesize advances in the identification of brain states associated with consciousness in animal models and physiological (sleep), pharmacological (anaesthesia) and pathological (disorders of consciousness) states of altered consciousness in humans. We show that in reduced consciousness the frequencies in which the brain operates are slowed down and that the pattern of functional communication is sparser, less efficient, and less complex. The results also highlight damaged resting-state networks, in particular the default mode network, decreased connectivity in long-range connections and especially in the thalamocortical loops. Next, we show that therapeutic approaches to treat disorders of consciousness, through pharmacology (e.g. amantadine, zolpidem), and (non-) invasive brain stimulation (e.g. transcranial direct current stimulation, deep brain stimulation) have shown partial effectiveness in promoting consciousness recovery. Although some features of conscious brain states may improve in response to neuromodulation, targeting often remains non-specific and does not always lead to (behavioural) improvements. The fields of brain state identification and neuromodulation of brain states in relation to consciousness are showing fascinating developments that, when integrated, might propel the development of new and better-targeted techniques for disorders of consciousness. We here propose a therapeutic framework for the identification and modulation of brain states to facilitate the interaction between the two fields. We propose that brain states should be identified in a predictive setting, followed by theoretical and empirical testing (i.e. in animal models, under anaesthesia and in patients with a disorder of consciousness) of neuromodulation techniques to promote consciousness in line with such predictions. This framework further helps to identify where challenges and opportunities lay for the maturation of brain state research in the context of states of consciousness. It will become apparent that one angle of opportunity is provided through the addition of computational modelling. Finally, it aids in recognizing possibilities and obstacles for the clinical translation of these diagnostic techniques and neuromodulation treatment options across both the multimodal and multi-species approaches outlined throughout the review., NA is research fellow, OG and AT are Research Associates, and SL is the research director at Fonds de la Recherche Scientifique (FRS-FNRS). JA is a postdoctoral fellow at the Fonds voor Wetenschappelijk Onderzoek (FWO) (1265522N). The study was further supported by the University and University Hospital of Liège, the BIAL Foundation, the Belgian National Funds for Scientific Research (FRS-FNRS), the European Union's Horizon 2020 Framework Programme for Research and Innovation under Specific Grant Agreement No. 945539 (Human Brain Project SGA3), the FNRS PDR project (T.0134.21), the ERA-Net FLAG-ERA JTC2021 project ModelDXConsciousness (Human Brain Project Partnering Project), the fund Generet, the King Baudouin Foundation, the Télévie Foundation, the European Space Agency (ESA) and the Belgian Federal Science Policy Office (BELSPO) in the framework of the PROgramme de Développement d'Expériences scientifiques (PRODEX Programme), the Public Utility Foundation `Université Européenne du Travail', `Fondazione Europea di Ricerca Biomedica', the BIAL Foundation, the Mind Science Foundation, the European Commission, the Fondation Leon Fredericq, the Mind-Care foundation, the DOCMA project (EU-H2020-MSCA-RISE-778234), the National Natural Science Foundation of China (Joint Research Project 81471100) and the European Foundation of Biomedical Research (FERB Onlus). EU grants ICT-36-2020-101016787 (DEEPER), EIC Pathfinder GAP-101130883 (PHOTOTHERAPORT), and -EIC-2023-PATHFINDEROPEN-101130650 (META-BRAIN), Government of Catalonia AGAUR [Centres de Recerca de Catalunya (CERCA) Programme, 2021-SGR-01410; AGAUR 2021-SGR-01165 - NEUROVIRTUAL], Ministerio de Ciencia e Innovación (MICINN) grants PID2019-111493RB-I00 (DEEP RED) and PID2022- 142609OB-I00 (EPILLUM), PID2020-112947RB-I00 financed by Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI)/10.13039/501100011033 (CORTICOMOD), and Fundaluce and 'la Caixa' foundations (ID 100010434, agreement LCF/PR/HR19/52160010).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Reversible photocontrol of dopaminergic transmission in wild-type animals

  • Matera, Carlo
  • Calvé Pérez, Pablo, 1993-
  • Casadó-Anguera, Verònica
  • Sortino, Rosalba
  • Gomila, Alexandre M.J.
  • Moreno, Estefanía
  • Gener, Thomas
  • Delgado-Sallent, Cristina
  • Nebot Forcada, Pau
  • Costazza, Davide
  • Conde-Berriozabal, Sara
  • Masana, Mercè
  • Hernando, Jordi
  • Casadó, Vicent
  • Puig Velasco, María Victoria
  • Gorostiza, Pau
Understanding the dopaminergic system is a priority in neurobiology and neuropharmacology. Dopamine receptors are involved in the modulation of fundamental physiological functions, and dysregulation of dopaminergic transmission is associated with major neurological disorders. However, the available tools to dissect the endogenous dopaminergic circuits have limited specificity, reversibility, resolution, or require genetic manipulation. Here, we introduce azodopa, a novel photoswitchable ligand that enables reversible spatiotemporal control of dopaminergic transmission. We demonstrate that azodopa activates D1-like receptors in vitro in a light-dependent manner. Moreover, it enables reversibly photocontrolling zebrafish motility on a timescale of seconds and allows separating the retinal component of dopaminergic neurotransmission. Azodopa increases the overall neural activity in the cortex of anesthetized mice and displays illumination-dependent activity in individual cells. Azodopa is the first photoswitchable dopamine agonist with demonstrated efficacy in wild-type animals and opens the way to remotely controlling dopaminergic neurotransmission for fundamental and therapeutic purposes., This research was funded by EU Horizon 2020 Framework Programme for Research and Innovation: Human Brain Project WaveScalES, Specific Grant Agreement 2 No. 785907 and Specific Grant Agreement 3 No. 945539; NEUROPA project, Grant Agreement No. 863214; DEEPER project ICT-36-2020-101016787; European Union Regional Development Fund within the framework of the ERDF Operational Program of Catalonia 2014-2020: CECH project; Ministry of Science and Innovation DEEP RED grant PID2019-111493RB-I00 funded by MCIN/AEI/10.13039/501100011033; Ministerio de Economía y Competitividad and European Regional Development Funds: Grant no. SAF2017-87629-R to V.C., SAF2016-80726-R to M.V.P., SAF2017-88076-R to M.M.; AGAUR/Generalitat de Catalunya: CERCA Programme; Generalitat de Catalunya: Grant no. 2017-SGR-1442 to P.G., 2017-SGR-1497 to V.C., 2017-SGR-210 to M.V.P., and 2017-SGR-00465 to J.H.; Fundaluce and “la Caixa” foundations: ID 100010434, grant agreement LCF/PR/HR19/52160010.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Adrenergic Modulation With Photochromic Ligands

  • Prischich, Davia|||0000-0001-6669-0436
  • Gomila, Alexandre|||0000-0003-0867-6171
  • Milla-Navarro, Santiago|||0000-0002-6947-5034
  • Sangüesa, Gemma|||0000-0002-6902-4372
  • Diez Alarcia, Rebeca|||0000-0002-0806-9825
  • Preda, Beatrice
  • Matera, Carlo|||0000-0001-6939-3859
  • Batlle, Montserrat|||0000-0002-3034-2023
  • Ramírez, Laura
  • Giralt, Ernest|||0000-0001-8381-1797
  • Hernando, Jordi|||0000-0002-1126-4138
  • Guasch, Eduard|||0000-0003-4238-5319
  • Meana, J. Javier|||0000-0002-7913-6714
  • de la Villa, Pedro|||0000-0001-9856-6616
  • Gorostiza, Pau|||0000-0002-7268-5577
Adrenoceptors are ubiquitous and mediate important autonomic functions as well as modulating arousal, cognition, and pain on a central level. Understanding these physiological processes and their underlying neural circuits requires manipulating adrenergic neurotransmission with high spatio-temporal precision. Here we present a first generation of photochromic ligands (adrenoswitches) obtained via azologization of a class of cyclic amidines related to the known ligand clonidine. Their pharmacology, photochromism, bioavailability, and lack of toxicity allow for broad biological applications, as demonstrated by controlling locomotion in zebrafish and pupillary responses in mice.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Photoswitchable dynasore analogs to control endocytosis with light

  • Camarero, Nuria|||0000-0003-3045-5180
  • Trapero, Ana|||0000-0003-4526-7895
  • Pérez-Jiménez, Ariadna
  • Macia, Eric
  • Gomila, Alexandre|||0000-0003-0867-6171
  • Martín-Quirós, Andrés|||0000-0003-4425-9914
  • Nevola, Laura
  • Llobet, Artur|||0000-0001-5797-6782
  • Llebaria, Amadeu|||0000-0002-8200-4827
  • Hernando, Jordi|||0000-0002-1126-4138
  • Giralt, Ernest|||0000-0001-8381-1797
  • Gorostiza, Pau|||0000-0002-7268-5577
The spatiotemporal control of cellular dynamic processes has great fundamental interest but lacks versatile molecular tools. Dynamin is a key protein in endocytosis and an appealing target to manipulate cell trafficking using patterns of light. We have developed the first photoswitchable small-molecule inhibitors of endocytosis (dynazos), by a stepwise design of the photochromic and pharmacological properties of dynasore, a dynamin inhibitor. We have characterized their photochromism with UV-visible and transient absorption spectroscopy and their biological activity using fluorescence microscopies and flow cytometry. Dynazos are water-soluble, cell permeable, and photostable, and enable fast, single-wavelength photoswitchable inhibition of clathrin-mediated endocytosis at micromolar concentration.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Reversible Photocontrol of Dopaminergic Transmission in Wild-Type Animals

  • Matera, Carlo|||0000-0001-6939-3859
  • Calvé, Pablo
  • Casadó-Anguera, Verònica|||0000-0001-8532-2954
  • Sortino, Rosalba|||0000-0002-8854-6782
  • Gomila, Alexandre|||0000-0003-0867-6171
  • Moreno, Estefanía|||0000-0002-2491-5753
  • Gener, Thomas Adrien|||0000-0001-9209-9228
  • Delgado-Sallent, Cristina|||0000-0002-2202-1043
  • Nebot, Pau
  • Costazza, Davide|||0000-0002-7876-0291
  • Conde Berriozabal, Sara|||0000-0002-3712-8046
  • Masana, Mercè|||0000-0003-1392-4774
  • Hernando, Jordi|||0000-0002-1126-4138
  • Casadó, Vicent|||0000-0002-1764-3825
  • Puig Velasco, Maria Victoria|||0000-0002-1490-4153
  • Gorostiza, Pau|||0000-0002-7268-5577
Understanding the dopaminergic system is a priority in neurobiology and neuropharmacology. Dopamine receptors are involved in the modulation of fundamental physiological functions, and dysregulation of dopaminergic transmission is associated with major neurological disorders. However, the available tools to dissect the endogenous dopaminergic circuits have limited specificity, reversibility, resolution, or require genetic manipulation. Here, we introduce azodopa, a novel photoswitchable ligand that enables reversible spatiotemporal control of dopaminergic transmission. We demonstrate that azodopa activates D1-like receptors in vitro in a light-dependent manner. Moreover, it enables reversibly photocontrolling zebrafish motility on a timescale of seconds and allows separating the retinal component of dopaminergic neurotransmission. Azodopa increases the overall neural activity in the cortex of anesthetized mice and displays illumination-dependent activity in individual cells. Azodopa is the first photoswitchable dopamine agonist with demonstrated efficacy in wild-type animals and opens the way to remotely controlling dopaminergic neurotransmission for fundamental and therapeutic purposes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Three-photon infrared stimulation of endogenous neuroreceptors in vivo

  • Sortino, Rosalba|||0000-0002-8854-6782
  • Cunquero, Marina|||0000-0001-8093-8186
  • Castro-Olvera, Gustavo|||0000-0001-9843-3581
  • Gelabert, Ricard|||0000-0001-6506-5786
  • Moreno, Miquel|||0000-0002-2784-1307
  • Riefolo, Fabio|||0000-0002-6762-2619
  • Matera, Carlo|||0000-0001-6939-3859
  • Fernàndez-Castillo, Noèlia|||0000-0001-9948-0312
  • Agnetta, Luca
  • Decker, Michael
  • Lluch, José M.|||0000-0002-7536-1869
  • Hernando, Jordi|||0000-0002-1126-4138
  • Loza-Alvarez, Pablo|||0000-0002-3129-1213
  • Gorostiza, Pau|||0000-0002-7268-5577
To interrogate neural circuits and crack their codes, in vivo brain activity imaging must be combined with spatiotemporally precise stimulation in three dimensions using genetic or pharmacological specificity. This challenge requires deep penetration and focusing as provided by infrared light and multiphoton excitation, and has promoted two-photon photopharmacology and optogenetics. However, three-photon brain stimulation in vivo remains to be demonstrated. We report the regulation of neuronal activity in zebrafish larvae by three-photon excitation of a photoswitchable muscarinic agonist at 50 pM, a billion-fold lower concentration than used for uncaging, and with mid-infrared light of 1560 nm, the longest reported photoswitch wavelength. Robust, physiologically relevant photoresponses allow modulating brain activity in wild-type animals with spatiotemporal and pharmacological precision. Computational calculations predict that azobenzene-based ligands have high three-photon absorption cross-section and can be used directly with pulsed infrared light. The expansion of three-photon pharmacology will deeply impact basic neurobiology and neuromodulation phototherapies.